MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Cash Flow Overview
Change in Cash
-$1,205,589
Unit: Dollar
Positive Cash Flow Breakdown
Loss from equity method investme...
Stock-based compensation expense
Trade accounts payable and accru...
Negative Cash Flow Breakdown
Accrued compensation related pa...
Prepaid expenses
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Cash Flow
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Net loss
-1,208,534
-1,150,152
-5,983,321
-1,137,673
Stock-based compensation expense
21,876
107,590
4,557,949
390,840
Loss from equity method investments
-
-91,582
-
-
Loss from equity method investment
-87,544
-
-211,268
176,056
Prepaid expenses
32,537
-6,397
-33,789
-40,468
Trade accounts payable and accrued expenses
6,815
-95,195
45,278
-214,533
Related party accrued interest and accrued compensation
-
161,505
-
-
Accrued compensation related party
-242,258
-
-
-
Net cash used in operating activities
-1,205,589
-1,201,283
-1,135,037
-1,096,954
Offering costs
-
-
158,421
112,569
Proceeds from related party
-
-
572,865
-
Proceeds from stock option exercises
-
-
-
297,792
Proceeds from common stock option exercises
-
-
888,282
-
Proceeds from sale of common stock
-
-
3,835,485
2,822,795
Repayment of advance payable to related party
0
330,607
-
-
Net cash (used) provided by financing activities
0
-330,607
4,840,419
3,008,018
Net decrease in cash
-1,205,589
-1,531,890
3,705,382
1,911,064
Cash, beginning of period
4,815,031
6,346,921
2,641,539
2,832,931
Cash, end of period
3,609,442
4,815,031
6,346,921
2,641,539
Page 1
Unit: Dollar. Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Cash Flow
Net decrease in cash
-$1,205,589
(42.66%↑ Y/Y)
something is missing
$161,505
Loss from equity
method investment
-$87,544
Stock-based compensation
expense
$21,876
(-98.40%↓ Y/Y)
Trade accounts
payable and accrued...
$6,815
(101.60%↑ Y/Y)
Net cash used in
operating activities
-$1,205,589
(50.38%↑ Y/Y)
Canceled cashflow
$277,740
Net loss
-$1,208,534
(63.61%↑ Y/Y)
Accrued compensation
related party
-$242,258
Prepaid expenses
$32,537
(-31.75%↓ Y/Y)
Buy us a coffee
MIRA PHARMACEUTICALS, INC. (MIRA)
MIRA PHARMACEUTICALS, INC. (MIRA)